GLATIRAMER for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 63 adverse event reports in the FDA FAERS database where GLATIRAMER was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for GLATIRAMER
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 5,003 | 10.8% | 2 | 181 |
| Multiple sclerosis relapse | 3,695 | 8.0% | 6 | 718 |
| Drug ineffective | 3,321 | 7.2% | 4 | 168 |
| Injection site reaction | 3,317 | 7.2% | 6 | 95 |
| Multiple sclerosis | 2,596 | 5.6% | 22 | 240 |
| Injection site erythema | 2,560 | 5.5% | 2 | 120 |
| Fatigue | 2,408 | 5.2% | 2 | 273 |
| Dyspnoea | 2,364 | 5.1% | 6 | 366 |
| Injection site mass | 2,172 | 4.7% | 0 | 92 |
| Injection site swelling | 1,836 | 4.0% | 1 | 91 |
| Fall | 1,701 | 3.7% | 7 | 501 |
| Injection site pruritus | 1,579 | 3.4% | 0 | 64 |
| Pain | 1,529 | 3.3% | 1 | 196 |
| Urticaria | 1,366 | 3.0% | 1 | 94 |
| Dizziness | 1,349 | 2.9% | 1 | 215 |
Other Indications for GLATIRAMER
Multiple sclerosis (27,144)
Product used for unknown indication (6,140)
Relapsing-remitting multiple sclerosis (1,965)
Relapsing multiple sclerosis (375)
Multiple sclerosis relapse (133)
Clinically isolated syndrome (59)
Primary progressive multiple sclerosis (30)
Progressive multiple sclerosis (21)
Rheumatoid arthritis (11)
Multiple sclerosis relapse prophylaxis (10)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)